Accelerating Drug Discovery Through Agentic AI: A Multi-Agent Approach to Laboratory Automation in the DMTA Cycle
Fuente:
arXiv
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Preprint |
| Published: |
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866915385690816512 |
|---|---|
| author | Fehlis, Yao Crain, Charles Jensen, Aidan Watson, Michael Juhasz, James Mandel, Paul Liu, Betty Mahon, Shawn Wilson, Daren Lynch-Jonely, Nick Leedom, Ben Fuller, David |
| author_facet | Fehlis, Yao Crain, Charles Jensen, Aidan Watson, Michael Juhasz, James Mandel, Paul Liu, Betty Mahon, Shawn Wilson, Daren Lynch-Jonely, Nick Leedom, Ben Fuller, David |
| contents | The pharmaceutical industry faces unprecedented challenges in drug discovery, with traditional approaches struggling to meet modern therapeutic development demands. This paper introduces a novel AI framework, Tippy, that transforms laboratory automation through specialized AI agents operating within the Design-Make-Test-Analyze (DMTA) cycle. Our multi-agent system employs five specialized agents - Supervisor, Molecule, Lab, Analysis, and Report, with Safety Guardrail oversight - each designed to excel in specific phases of the drug discovery pipeline. Tippy represents the first production-ready implementation of specialized AI agents for automating the DMTA cycle, providing a concrete example of how AI can transform laboratory workflows. By leveraging autonomous AI agents that reason, plan, and collaborate, we demonstrate how Tippy accelerates DMTA cycles while maintaining scientific rigor essential for pharmaceutical research. The system shows significant improvements in workflow efficiency, decision-making speed, and cross-disciplinary coordination, offering a new paradigm for AI-assisted drug discovery. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2507_09023 |
| institution | arXiv |
| publishDate | 2025 |
| record_format | arxiv |
| spellingShingle | Accelerating Drug Discovery Through Agentic AI: A Multi-Agent Approach to Laboratory Automation in the DMTA Cycle Fehlis, Yao Crain, Charles Jensen, Aidan Watson, Michael Juhasz, James Mandel, Paul Liu, Betty Mahon, Shawn Wilson, Daren Lynch-Jonely, Nick Leedom, Ben Fuller, David Software Engineering Artificial Intelligence Multiagent Systems The pharmaceutical industry faces unprecedented challenges in drug discovery, with traditional approaches struggling to meet modern therapeutic development demands. This paper introduces a novel AI framework, Tippy, that transforms laboratory automation through specialized AI agents operating within the Design-Make-Test-Analyze (DMTA) cycle. Our multi-agent system employs five specialized agents - Supervisor, Molecule, Lab, Analysis, and Report, with Safety Guardrail oversight - each designed to excel in specific phases of the drug discovery pipeline. Tippy represents the first production-ready implementation of specialized AI agents for automating the DMTA cycle, providing a concrete example of how AI can transform laboratory workflows. By leveraging autonomous AI agents that reason, plan, and collaborate, we demonstrate how Tippy accelerates DMTA cycles while maintaining scientific rigor essential for pharmaceutical research. The system shows significant improvements in workflow efficiency, decision-making speed, and cross-disciplinary coordination, offering a new paradigm for AI-assisted drug discovery. |
| title | Accelerating Drug Discovery Through Agentic AI: A Multi-Agent Approach to Laboratory Automation in the DMTA Cycle |
| topic | Software Engineering Artificial Intelligence Multiagent Systems |
| url | https://arxiv.org/abs/2507.09023 |